alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
H. R. 7777 

One Hundred Eighteenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Wednesday, 

the third day of January, two thousand and twenty-four 

An Act 

To increase, effective as of December 1, 2024, the rates of compensation for veterans 

with service-connected disabilities and the rates of dependency and indemnity 

compensation for the survivors of certain disabled veterans, and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Veterans’ Compensation Costof-Living Adjustment Act of 2024’’. 

SEC. 2. INCREASE IN RATES OF DISABILITY COMPENSATION AND 

DEPENDENCY AND INDEMNITY COMPENSATION. 

(a) RATE ADJUSTMENT.—Effective on December 1, 2024, the 

Secretary of Veterans Affairs shall increase, in accordance with 

subsection (c), the dollar amounts in effect on November 30, 2024, 

for the payment of disability compensation and dependency and 

indemnity compensation under the provisions specified in subsection 

(b). 

(b) AMOUNTS TO BE INCREASED.—The dollar amounts to be 

increased pursuant to subsection (a) are the following: 

(1) WARTIME DISABILITY COMPENSATION.—Each of the dollar 

amounts under section 1114 of title 38, United States Code. 

(2) ADDITIONAL COMPENSATION FOR DEPENDENTS.—Each of 

the dollar amounts under section 1115(1) of such title. 

(3) CLOTHING ALLOWANCE.—The dollar amount under section 1162 of such title. 

(4) DEPENDENCY AND INDEMNITY COMPENSATION TO SURVIVING SPOUSE.—Each of the dollar amounts under subsections 

(a) through (d) of section 1311 of such title. 

(5) DEPENDENCY AND INDEMNITY COMPENSATION TO CHILDREN.—Each of the dollar amounts under sections 1313(a) and 

1314 of such title. 

(c) DETERMINATION OF INCREASE.—Each dollar amount 

described in subsection (b) shall be increased by the same percentage as the percentage by which benefit amounts payable under 

title II of the Social Security Act (42 U.S.C. 401 et seq.) are 

increased effective December 1, 2024, as a result of a determination 

under section 215(i) of such Act (42 U.S.C. 415(i)). 

(d) SPECIAL RULE.—The Secretary of Veterans Affairs may 

adjust administratively, consistent with the increases made under 

subsection (a), the rates of disability compensation payable to persons under section 10 of Public Law 85–857 (72 Stat. 1263) who 

have not received compensation under chapter 11 of title 38, United 

States Code. 
H. R. 7777—2 

SEC. 3. PUBLICATION OF ADJUSTED RATES. 

The Secretary of Veterans Affairs shall publish in the Federal 

Register the amounts specified in section 2(b), as increased under 

that section, not later than the date on which the matters specified 

in section 215(i)(2)(D) of the Social Security Act (42 U.S.C. 

415(i)(2)(D)) are required to be published by reason of a determination made under section 215(i) of such Act during fiscal year 2025. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          APR-30-1999
<PERIOD-START>                              MAY-1-1998
<PERIOD-END>                               APR-30-1999
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                    8,445
<ALLOWANCES>                                         0
<INVENTORY>                                      6,056
<CURRENT-ASSETS>                                57,532
<PP&E>                                         478,596
<DEPRECIATION>                                  69,788
<TOTAL-ASSETS>                                 466,339
<CURRENT-LIABILITIES>                          534,456
<BONDS>                                        210,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     4,182,794
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   466,339
<SALES>                                          2,813
<TOTAL-REVENUES>                                 2,813
<CGS>                                              953
<TOTAL-COSTS>                                      953
<OTHER-EXPENSES>                             1,192,983
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              28,312
<INCOME-PRETAX>                            (1,219,435)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,219,435)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,219,435)
<EPS-BASIC>                                    (.13)
<EPS-DILUTED>                                    (.13)


</TABLE>
---

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Smart-tek Solutions,
Inc., (the "Company") on Form 10K for the year ending June 30, 2010 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Brian Bonar, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of
2002, that, to the best of the undersigneds knowledge and belief:

(1) The Report fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and

(2) The information contained in
the Report fairly presents, in all material respects, the financial condition
and result of operations of the Company.

/s/ Brian BonarBrian BonarChief Executive
Officer, President and Director

October 15, 2010

---
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.1025 Ferric ammonium citrate. ( a ) *Identity.* The color additive ferric ammonium citrate consists of complex chelates prepared by the interaction of ferric hydroxide with citric acid in the presence of ammonia. The complex chelates occur in brown and green forms, are deliquescent in air, and are reducible by light.
( b ) *Specifications.* Ferric ammonium citrate shall conform to the following specifications and shall be free from impurities other than those named to the extent that such impurities may be avoided by good manufacturing practice: Iron (as Fe), not less than 14.5 percent and not more than 18.5 percent. Lead (as Pb), not more than 20 p/m. Arsenic (as As), not more than 3 p/m.
( c ) *Uses and restrictions.* Ferric ammonium citrate may be safely used in combination with pyrogallol (as listed in § 73.1375), for coloring plain and chromic catgut sutures for use in general and ophthalmic surgery subject to the following conditions: ( 1 ) The dyed suture shall conform in all respects to the requirements of the United States Pharmacopeia XX (1980).
( 2 ) The level of the ferric ammonium citrate-pyrogallol complex shall not exceed 3 percent of the total weight of the suture material.
( 3 ) When the sutures are used for the purposes specified in their labeling, there is no migration of the color additive to the surrounding tissue.
( 4 ) If the suture is a new drug, an approved new drug application, pursuant to section 505 of the act, is in effect for it.
( d ) *Labeling.* The labeling of the color-additive shall conform to the requirements of § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health and therefore batches thereof are exempt from the requirements of section 721(c) of the act.
[42 FR 15643, Mar. 22, 1977, as amended at 49 FR 10089, Mar. 19, 1984]
COURT OF APPEALS

	SECOND DISTRICT OF TEXAS

	FORT WORTH

	NO. 2-07-253-CV

IN RE GREGORY THOMAS BELDING	RELATOR

	------------

	ORIGINAL PROCEEDING

	------------

	MEMORANDUM OPINION1

	------------

	The court has considered relator’s petition for writ of mandamus and is of the opinion that relief should be denied.  Accordingly, relator’s petition for writ of mandamus is denied.

	Relator shall pay all costs of this original proceeding, for which let execution issue.

								PER CURIAM

PANEL M: LIVINGSTON and MCCOY, JJ. 

DELIVERED: July 17, 2007
# C_2016038EN.01005602.xml

| 1.2.2016 | EN | Official Journal of the European Union | C 38/56 |
| --- | --- | --- | --- |

1.2.2016

EN

Official Journal of the European Union

C 38/56

---

Order of the General Court of 1 December 2015 — Banco Espírito Santo v Commission

(Case T-814/14) (1)

1

((Action for annulment - State aid - Aid to the Portuguese authorities for the resolution of the financial institution Banco Espírito Santo SA - Creation of a bridge bank - Decision not to raise objections - Commitments made by the Portuguese authorities - Monitoring of compliance with their commitments by a trustee - Payment of the trustee by the bad bank - Application for partial annulment - Inadmissible))

(2016/C 038/75)

Language of the case: Portuguese

Parties

Parties

Applicant: Banco Espírito Santo SA (Lisbon, Portugal) (represented by: M. Gorjão-Henriques and L.Bordalo e Sá, lawyers)

Applicant:

Defendant: European Commission (represented by: L. Flynn, M. França and P.-J Loewenthal, Agents)

Defendant:

Re:

Re:

Application for annulment of Points 9 and 18 of Annex II to Commission Decision C (2014) 5682 final, of 3 August 2014, State aid No SA.39250 (2014/N) — Portugal, Resolution of Banco Espírito Santo, S.A., in so far as they impose, or may be interpreted as imposing, on the applicant the responsibility for ensuring the remuneration or payment of any other costs of the Monitoring Trustee with respect to the commitments made by the Portuguese Republic:

Operative part of the order

Operative part of the order

| 1. | The action is dismissed as inadmissible. |
| --- | --- |

1.

The action is dismissed as inadmissible.

| 2. | There is no need to give a ruling on the application for leave to intervene lodged by the Portuguese Republic. |
| --- | --- |

2.

There is no need to give a ruling on the application for leave to intervene lodged by the Portuguese Republic.

| 3. | Banco Espirito Santo SA is ordered to bear its own costs and to pay those incurred by the European Commission. |
| --- | --- |

3.

Banco Espirito Santo SA is ordered to bear its own costs and to pay those incurred by the European Commission.

| 4. | Banco Espirito Santo SA, the European Commission and the Portuguese Republic are each ordered to bear their own costs relating for the application for leave to intervene. |
| --- | --- |

4.

Banco Espirito Santo SA, the European Commission and the Portuguese Republic are each ordered to bear their own costs relating for the application for leave to intervene.

---

(1)  OJ C 118, 13.4.2015.

1

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
CONSOLIDATED  BALANCE SHEETS  (UNAUDITED) AS OF MAY 2, 1999 AND NOVEMBER 1, 1998
AND THE CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) FOR THE QUARTERS ENDED
MAY 2, 1999 AND MAY 3, 1998.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          OCT-31-1999
<PERIOD-START>                             NOV-02-1998
<PERIOD-END>                               MAY-02-1999
<EXCHANGE-RATE>                                      1
<CASH>                                          57,328
<SECURITIES>                                         0
<RECEIVABLES>                                  315,493
<ALLOWANCES>                                    27,337
<INVENTORY>                                    449,245
<CURRENT-ASSETS>                               818,290
<PP&E>                                         216,039
<DEPRECIATION>                                 120,369
<TOTAL-ASSETS>                                 948,573
<CURRENT-LIABILITIES>                          763,475
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           205
<OTHER-SE>                                     150,906
<TOTAL-LIABILITY-AND-EQUITY>                   948,573
<SALES>                                      1,656,541
<TOTAL-REVENUES>                             1,656,541
<CGS>                                        1,569,903
<TOTAL-COSTS>                                1,569,903
<OTHER-EXPENSES>                                12,260
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 992
<INCOME-PRETAX>                              (165,806)
<INCOME-TAX>                                  (18,465)
<INCOME-CONTINUING>                          (147,341)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (147,341)
<EPS-BASIC>                                     (7.19)
<EPS-DILUTED>                                   (7.19)


</TABLE>
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1535 Ornithine carbamyl transferase test system. ( a ) *Identification.* An ornithine carbamyl transferase test system is a device intended to measure the activity of the enzyme ornithine carbamyl transferase (OCT) in serum. Ornithine carbamyl transferase measurements are used in the diagnosis and treatment of liver diseases, such as infectious hepatitis, acute cholecystitis (inflammation of the gall bladder), cirrhosis, and liver metastases.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2307, Jan. 14, 2000]
#### § 582.30 Natural substances used in conjunction with spices and other natural seasonings and flavorings.

Natural substances used in conjunction with spices and other natural seasonings and flavorings that are generally recognized as safe for their intended use, within the meaning of section 409 of the act, are as follows:

| Common name | Botanical name of plant source |
| --- | --- |
| Algae, brown (kelp) | *Laminaria* spp. and *Nereocystis* spp. |
| Algae, red | *Porphyra* spp. and *Rhodymenia palmata* (L.) Grev. |
| Dulse | *Rhodymenia palmata* (L.) |
```

[Federal Register Volume 75, Number 42 (Thursday, March 4, 2010)]
[Notices]
[Page 9955]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4465]

-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

Labor Surplus Area Classification Under Executive Orders 12073 
and 10582

AGENCY: Employment and Training Administration, Labor.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The purpose of this notice is to update the 2010 Labor Surplus 
Areas annual list published in the Federal Register, Vol. 74, No. 209, 
Friday, October 30, 2009, pages 56217-56239.

DATES: Effective Date: The update of the annual list of labor surplus 
areas is effective immediately for all states, the District of 
Columbia, and Puerto Rico.

FOR FURTHER INFORMATION CONTACT: Samuel Wright, Office of Workforce 
Investment, Employment and Training Administration, 200 Constitution 
Avenue, NW., Room S-4231, Washington, DC 20210. Telephone: (202) 693-
2870 (This is not a toll-free number).

SUPPLEMENTARY INFORMATION: For supplementary, eligibility, 
classification procedures and petition for exceptional circumstances 
procedure information refer to the original 2010 Labor Surplus Area 
list at http://edocket.access.gpo.gov/2009/pdf/E9-26165.pdf.

    Signed at Washington, DC, this 25th day of February 2010.
Jane Oates,
Assistant Secretary for Employment and Training Administration.
[FR Doc. 2010-4465 Filed 3-3-10; 8:45 am]
BILLING CODE 4510-FT-P
```
# C_2015198EN.01003801.xml

| 15.6.2015 | EN | Official Journal of the European Union | C 198/38 |
| --- | --- | --- | --- |

15.6.2015

EN

Official Journal of the European Union

C 198/38

---

Judgment of the General Court of 28 April 2015 — Volkswagen v OHIM (EXTRA)

(Case T-216/14) (1)

1

((Community trade mark - Application for Community word mark EXTRA - Mark comprised of an advertising slogan - Absolute ground for refusal - Lack of distinctive character - Article 7(1)(b) of Regulation (EC) No 207/2009))

(2015/C 198/51)

Language of the case: German

Parties

Parties

Applicant: Volkswagen AG (Wolfsburg, Germany) (represented by: U. Sander and J. Eberhardt, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: initially M. Fischer, then A. Schifko, agents)

Defendant:

Re:

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 6 February 2014 (Case R 1788/2013-1) relating to the application for registration of the word sign EXTRA as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the appeal; |
| --- | --- |

1.

Dismisses the appeal;

| 2. | Orders Volkswagen AG to pay the costs. |
| --- | --- |

2.

Orders Volkswagen AG to pay the costs.

---

(1)  OJ C 194, 24.6.2014.

1

---
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.7375 Glutathione reductase assay. ( a ) *Identification.* A glutathione reductase assay is a device used to determine the activity of the enzyme glutathione reductase in serum, plasma, or erythrocytes by such techniques as fluorescence and photometry. The results of this assay are used in the diagnosis of liver disease, glutathione reductase deficiency, or riboflavin deficiency.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
[45 FR 60616, Sept. 12, 1980, as amended at 84 FR 71799, Dec. 30, 2019]
§ 520.1445 Milbemycin oxime and praziquantel. ( a ) *Specifications.* Each chewable tablet contains: ( 1 ) 2.3 milligrams (mg) milbemycin oxime and 22.8 mg praziquantel;
( 2 ) 5.75 mg milbemycin oxime and 57 mg praziquantel;
( 3 ) 11.5 mg milbemycin oxime and 114 mg praziquantel; or
( 4 ) 23 mg milbemycin oxime and 228 mg praziquantel.
( b ) *Sponsor.* See No. 058198 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Dogs* — ( i ) *Amount.* Administer orally, once a month, a minimum dosage of 0.23 mg per pound (mg/lb) of body weight (0.5 mg per kilogram (mg/kg)) milbemycin oxime and 2.28 mg/lb of body weight (5 mg/kg) praziquantel.
( ii ) *Indications for use.* For the prevention of heartworm disease caused by *Dirofilaria immitis* and for the treatment and control of adult roundworm (*Toxocara canis, Toxascaris leonina*), adult hookworm (*Ancylostoma caninum*), adult whipworm (*Trichuris vulpis*), and adult tapeworm (*Taenia pisiformis, Echinococcus multilocularis, E. granulosus,* and *Dipylidium caninum*) infections in dogs and puppies 2 pounds of body weight or greater and 6 weeks of age and older.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) [Reserved]
[77 FR 47512, Aug. 9, 2012, as amended at 82 FR 58556, Dec. 13, 2017]
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 01-7516

JOHN NORFLEET WARD, III,

Petitioner - Appellant,

versus

RONALD J. ANGELONE, Director of the Virginia

Department of Corrections,

Respondent - Appellee.

Appeal from the United States District Court for the Eastern

District of Virginia, at Norfolk. Jerome B. Friedman, District

Judge. (CA-00-353-2)

Submitted: February 27, 2002 Decided: May 14, 2002

Before WILKINS, MOTZ, and TRAXLER, Circuit Judges.

Dismissed by unpublished per curiam opinion.

John Norfleet Ward, III, Appellant Pro Se. Donald Eldridge Jeffrey,

III, OFFICE OF THE ATTORNEY GENERAL OF VIRGINIA, Richmond,

Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

John Norfleet Ward, III, appeals the district court’s order

denying relief on his petition filed under 28 U.S.C.A. § 2254 (West

1994 & Supp. 2001). We have reviewed the record and the district

court’s opinion and find no reversible error. Accordingly, we deny

a certificate of appealability and dismiss the appeal on the

reasoning of the district court. See Ward v. Angelone, No. CA-00-

353-2 (E.D. Va. Aug. 23, 2001). Furthermore, while we grant Ward’s

motion “to include newly discovered evidence for review with

appeal,” our review of those materials does not alter our

conclusion. We dispense with oral argument because the facts and

legal contentions are adequately presented in the materials before

the court and argument would not aid the decisional process.

DISMISSED
```

[108th Congress Public Law 253]
[From the U.S. Government Printing Office]

[DOCID: f:publ253.108]

[[Page 118 STAT. 687]]

Public Law 108-253
108th Congress

                                 An Act

 
To designate the facility of the United States Postal Service located at 
 223 South Main Street in Roxboro, North Carolina, as the ``Oscar Scott 
  Woody Post Office Building''. <<NOTE: June 25, 2004 -  [H.R. 3740]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION.

    The facility of the United States Postal Service located at 223 
South Main Street in Roxboro, North Carolina, shall be known and 
designated as the ``Oscar Scott Woody Post Office Building''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the facility referred to in section 1 
shall be deemed to be a reference to the ``Oscar Scott Woody Post Office 
Building''.

    Approved June 25, 2004.

LEGISLATIVE HISTORY--H.R. 3740 (S. 2153):
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 150 (2004):
            May 18, considered and passed House.
            June 9, continued and passed Senate.

                                  <all>
```
<PAGE>   1


                                                                    EXHIBIT 23.3



                       CONSENT OF INDEPENDENT ACCOUNTANTS



     We hereby consent to the use in this Registration Statement on Form S-1/A
of our report dated April 24, 1998 relating to the financial statements of
Arcxel Technologies, Inc., which appears in such Registration Statement. We also
consent to the references to us under the headings "Experts" and "Selected
Financial Data" in such Prospectus. However, it should be noted that
PricewaterhouseCoopers LLP has not prepared or certified "Selected Financial
Data" in such Registration Statement.



/s/ PricewaterhouseCoopers LLP

------------------------------------

PricewaterhouseCoopers LLP


Seattle, Washington


August 12, 1999
§ 582.5273 Cystine. ( a ) *Product.* Cystine (L- and DL-forms).
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.